...
首页> 外文期刊>Human Molecular Genetics >hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.
【24h】

hnRNP-G promotes exon 7 inclusion of survival motor neuron (SMN) via direct interaction with Htra2-beta1.

机译:hnRNP-G通过与Htra2-beta1直接相互作用,促进生存运动神经元(SMN)的外显子7包含。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Proximal spinal muscular atrophy (SMA) is a common motor neuron disease caused by homozygous loss of the survival motor neuron gene (SMN1). SMN2, a nearly identical copy of the gene and present in all SMA patients, fails to provide protection from SMA, due to the disruption of an exonic splicing enhancer (ESE) by a single translationally silent nucleotide exchange, which causes alternative splicing of SMN2 exon 7. Identification of splicing factors that stimulate exon 7 inclusion and thereby produce sufficient amounts of full-length transcripts from the SMN2 gene is of great importance for therapy approaches. Here, by use of in vivo splicing assays, we identified the protein hnRNP-G and its paralogue RBM as two novel splicing factors that promote the inclusion of SMN2 exon 7. Moreover, hnRNP-G and RBM non-specifically bind RNA, but directly and specifically bind Htra2-beta1, an SR-like splicing factor which we have previously shown to stimulate inclusion of exon 7 through a direct interaction with the AG-rich ESE in SMN2 exon 7 pre-mRNA. By using deletion mutants of hnRNP-G, we show that the specific protein-protein interaction of hnRNP-G with Htra2-beta1 mediates the inclusion of SMN2 exon 7 rather than the non-specific interaction of hnRNP-G with SMN pre-mRNA. Additionally, we show for the first time that recombinant trans-acting splicing factors such as hnRNP-G and Htra2-beta1 are also effective on endogenous SMN2 transcripts and increase the endogenous SMN protein level. Finally, we suggest a model of how the exon 7 mRNA processing is regulated by the splicing factors identified so far.
机译:近端脊髓性肌萎缩症(SMA)是由存活运动神经元基因(SMN1)的纯合缺失引起的常见运动神经元疾病。 SMN2是该基因的几乎相同的副本,存在于所有SMA患者中,由于单个翻译沉默核苷酸交换破坏了外显子剪接增强子(ESE),导致无法提供SMA保护,从而导致SMN2外显子的选择性剪接。 7.鉴定刺激外显子7包含并由此从SMN2基因产生足够量的全长转录本的剪接因子对于治疗方法非常重要。在这里,通过体内剪接实验,我们确定了蛋白hnRNP-G及其旁系同源蛋白RBM为两个新的剪接因子,可促进SMN2外显子7的包含。此外,hnRNP-G和RBM非特异性结合RNA,但直接并特异性结合Htra2-beta1,这是一种SR样剪接因子,我们先前已证明它通过与SMN2外显子7前mRNA中富含AG的ESE直接相互作用来刺激外显子7包含在内。通过使用hnRNP-G的缺失突变体,我们显示hnRNP-G与Htra2-beta1的特定蛋白相互作用会介导SMN2外显子7的包含,而不是hnRNP-G与SMN pre-mRNA的非特异性相互作用。此外,我们首次显示重组反式剪接因子,例如hnRNP-G和Htra2-beta1对内源SMN2转录本也有效,并增加了内源SMN蛋白水平。最后,我们提出了一个模型,该模型目前为止已确定的剪接因子如何调控外显子7 mRNA的加工。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号